Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II study of 普那利单抗 for acute gouty arthritis
CTR20260681Phase 2Active
- Sponsor
- Tianjing Biopharma
- Start
- Apr 2026
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of betamethasone in acute gout flare, sponsored by Tianjing Biopharma. Started Apr 2026; status: active.
02
Drugs
betamethasone
03
Conditions
acute gout flare
Beyond the preview
Go deeper on CTR20260681.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20260681.